The Deterioration of Articular Cartilage in Osteoarthritis by Corticosteroid Injections

Ross Hauser, MDRoss Hauser, MD


The hallmark feature of osteoarthritis is the breakdown in the articular cartilage  of joints such as the knee and hip. Both animal and human research has consistently shown that corticosteroid injections into normal and degenerated knees accelerate the arthritic process. A summary of the effects of the intraarticular corticosteroids on articular cartilage includes: a decrease of protein and matrix synthesis, matrix hyaline appearance becomes fibrotic, clumping of collagen, alteration in chondrocyte cell shape, chondrocyte cell proliferation inhibited, chondrocyte cytoxicity enhanced, loss of chondrocytes, surface deterioration including edema, pitting, shredding, ulceration and erosions, inhibition of articular cartilage metabolism, articular cartilage necrosis, thinning of articular cartilage, decrease in cartilage growth and repair, formation of articular cartilage cysts, and ultimately articular cartilage destruction.

When researchers microscopically and radiologically examine human joints after corticosteroid injections, the same results are found in humans as in animals. Intraarticular corticosteroid injections accelerate the osteoarthritic degenerative process. Because of this possibility, organizations such as the American College of Rheumatology acknowledge, “It is generally recommended, although not well supported by published data, that injection of corticosteroids in a given joint not be performed more than three to four times in a given year because of concern about the possible development of progressive cartilage damage through repeated injection in the weight-bearing joints.” It is this author’s opinion that there is no doubt that the rise of osteoarthritis, as well as the number of hip replacements and knee replacements , is a direct result of the injection of corticosteroids into these joints.

Osteoarthritis (OA) is a major cause of pain and disability, as well as cost, to both the individual and society. The average direct out-of-pocket expenditure of OA is approximately $2600 per person per year, but the total annual cost per person (including lost productivity) is between $5700 and $9600.

Continue this article at The Journal of Prolotherapy:
Deterioration of Articular Cartilage

Find a Doctor Near You
If you found this article interesting and would like to find out if you are a good Prolotherapy candidate, click here to search for Regenerative Medicine doctors in your area.